[Perioperative teicoplanin prophylaxis in patients undergoing breast reconstruction with the abdominal wall. A case-control study]. / Profilassi perioperatoria con teicoplanina in pazienti sottoposte a ricostruzione mammaria con retto addominale. Studio caso-controllo.

The authors report the results of a randomized clinical trial of antibiotic prophylaxis of postoperative infection following breast reconstruction by transposition of rectus abdominis myocutaneous flap (TRAMF). The aim was to evaluate the efficacy and tolerability of a short-term parenteral prophylaxis with Teicoplanin and the end-point of the study was the evaluation of wound contamination assessed by means of microbiologic culture of drainage fluid. From October 1990 to March 1992 38 patients were recruited: 20 patients in the antibiotic prophylaxis arm and 18 patients in the control group. Analysis of drainage fluids showed a higher contamination rate (15/18 = 83%) in the control group as compared to the prophylaxis arm (2/20 = 10%) (p < 0.0001). Moreover, 11 patients in the control arm suffered from fever > 37.5 degrees C for at least 3 days as compared to 1 patient in the antibiotic prophylaxis group; the postoperative stay was 13.3 +/- 4.3 and 9.0 +/- 1.6 in the control and antibiotic arm respectively. No antibiotic related side effects were evidenced through the study. These results seem to confirm the value of parenteral short-term antibiotic prophylaxis of postoperative infection in such kind of "clean" operative procedure.

[A clinico-microbiological assessment of patients who have undergone breast reconstruction with a myocutaneous flap of the rectus abdominis]. / Valutazione clinico-microbiologica delle pazienti sottoposte a ricostruzione mammaria con lembo-miocutaneo di retto addominale.

In plastic surgery a minor complication such as wound infection can cause a lot of damage, because it can put back flap revascularization or it can stop wound healing properly. So the final result is not as good as it should be. In head-neck and in breast reconstruction with prostheses there are set-treatments of antibiotic prophylaxis; while in breast reconstruction with myocutaneous flaps it is very indecisive where antibiotics are concerned. This fact has encouraged us to evaluate bacteria causing infective complications in patients who have had breast reconstruction with TRAMF. In this operation there are 4 conditions which could give rise to microbiological contamination: 1) duration of operation (about 4 hours); 2) wide and prolonged tissue exposure; 3) areas of ischemic tissue or liponecrosis; 4) drainage. In this study we have shown the percentage of bacterial infections and the type of bacteria responsible for these complications in a group of patients who had already undergone breast reconstruction with TRAMF.

Selection of pre-operative haematobiochemical parameters for the identification of patients 'at risk of infection' undergoing surgery for gastro-intestinal cancer.

Sixty-three patients were given a complete laboratory screening before undergoing surgical treatment for cancer of the digestive tract. The values of all these parameters were correlated with the incidence of postoperative infections, with the aim of identifying those markers which could be useful for the pre-operative selection of the patients at risk of infection. Patients who developed postoperative infections showed a significant pre-operative reduction of total serum proteins (P less than 0.02), albumins (P less than 0.02), beta-globulins (P less than 0.01) and C3c (P less than 0.05), while alpha 1-globulins were slightly, but not significantly, increased. The possible clinical applications of these parameters, to develop a predictive model which may help identify the patients at risk of infection, are discussed.